Crime Scene Investigation (CSI) methods could help in the battle against hospital infections
Study published in Journal of Hospital Infection
London, UK, 22 April 2008 - Inspired by the popular television drama CSI, investigators in the Netherlands have trialed methods used by forensic scientists at crime scenes to highlight infection risks in their hospital. Researchers at Deventer Hospital used Luminol, a chemical used by crime scene investigators, to detect traces of blood in their haemodialysis unit. Luminol reacts with microscopic amounts of blood to produce bright blue luminescence, which allows investigators to track invisible blood splashes in the environment. The results of this experiment are reported in a new study, published in the Journal of Hospital Infection.
Bergervoet et al tested their apparently clean unit with Luminol. They found traces of blood on many surfaces including cupboard handles, telephones, computer keyboards, side tables and the floor, even though some of these surfaces had been cleaned. They expect that these results can be reproduced in other hospitals that plan to use Luminol in the future as described in their paper.
The group of researchers suggests that following on from their research, Luminol could be used as part of a hospital infection control regimen, in order to highlight risks associated with the contamination of the hospital environment with blood. Bergervoet et al specifically discuss the possibility that the hepatitis C virus may be transmitted via such environmental contamination.
Corresponding author Dr Paul Bergervoet of Deventer Ziekenhuis commented: “The aim of this article is to introduce this method to the infection control professionals so it can be used to monitor cleaning and disinfection procedures and alert healthcare workers to the possibility of contamination of the hospital environment with blood.”
# # #
Notes to Editors:
“Application of the forensic Luminol for blood and infection control” by PWM Bergervoet, N van Riessen, FW Sebens and WC van der Zwet,appears in the Journal of Hospital Infection, doi:10.1016/j.jhin.2008.01.026, published by Elsevier on behalf of the Hospital Infection Society. For courtesy review copies of the article please contact email@example.com
For further commentary, please contact: Dre Paul Bergervoet, Department of Infection Control, Deventer Ziekenhuis, PO Box 5001, 7400 GC Deventer, The Netherlands. Tel: +31 570 666666 Fax: +31 570 626477 Email: firstname.lastname@example.org
Journal of Hospital Infection
Journal of Hospital Infection (JHI) is published by Elsevier on behalf of the Hospital Infection Society www.his.org.uk on a monthly basis. The Journal publishes original articles in the field of hospital-acquired infection and related subjects. JHI seeks to promote collaboration between the many disciplines in infection control in different countries resulting in multidisciplinary and international coverage of the latest developments in this crucial area.
Elsevier is a world-leading provider of information solutions that enhance the performance of science, health, and technology professionals, empowering them to make better decisions, deliver better care, and sometimes make groundbreaking discoveries that advance the boundaries of knowledge and human progress. Elsevier provides web-based, digital solutions — among them ScienceDirect, Scopus, Research Intelligence and ClinicalKey— and publishes over 2,500 journals, including The Lancet and Cell, and more than 35,000 book titles, including a number of iconic reference works. Elsevier is part of RELX Group, a world-leading provider of information and analytics for professional and business customers across industries. www.elsevier.com
+44 7424 4469